PRRT Officially Launched in New Zealand

PRRT Officially Launched in New Zealand

On July 14, New Zealand patients celebrated a great leap forward in NET cancer care. The New Zealand Government announced the launch of Peptide Receptor Radionuclide Therapy (PRRT) as a national cancer treatment. The service will be based in the largest city –...
NCUK Barriers Survey Results

NCUK Barriers Survey Results

The purpose of the NCUK Barriers Survey was to consolidate and add to previous national and global neuroendocrine cancer (NC)* patient experience surveys and reports, to gain further insights into the patient pathway for those diagnosed with NC. From initial symptoms,...